Virpax Pharmaceuticals In... (VRPX)

0.27

0.02 (9.76%)

At close: Apr 28, 2025, 12:59 PM

Virpax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-3.39M	-2.01M	-3.45M	-3.22M	-4.56M	-5.99M	-3.11M	-1.52M	-2.99M	-7.64M	-5.88M	-5.14M	-4.12M	-3.22M	-2.34M	-2.38M	-705.21K	-1.71M	-1.27M	-656.5K	-700.01K	-1.03M	-787.26K	-787.26K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	7.2K	-17.73K	72.51K	72.72K	-9.63K	195.56K	218.26K	140.58K	138.28K	150.72K	244.7K	211.34K	141.15K	141.77K	321.43K	369.88K	335.55K	435.42K	571.69K	130.99K	121.39K	132.14K	212.31K	212.31K
Other Working Capital	512.2K	-2.22M	544.4K	-4.58M	1.56M	3.15M	711.59K	-199.65K	4.39M	268.16K	607.53K	-1.22M	-1.71M	-97.04K	34.13K	-936.78K	-217	88.19K	-95.06K	-6K	72.6K	-51.27K	-6.69K	-6.69K
Other Non-Cash Items	n/a	n/a	n/a	72.72K	-9.63K	195.56K	218.26K	140.58K	138.28K	150.72K	244.7K	211.34K	141.15K	-126.56K	34.05K	30.7K	18.33K	121.09K	-20.28K	34.08K	32.74K	673.23K	287.8K	287.8K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	512.2K	-2.45M	1.73M	-4.58M	1.56M	3.15M	711.59K	-628.42K	1.28M	1.99M	904.01K	-1.12M	-945.84K	-1.54M	190.43K	-1.1M	200.5K	508.25K	350.15K	269.03K	279.63K	-51.27K	-6.69K	-6.69K
Operating Cash Flow	-2.87M	-4.47M	-1.64M	-7.73M	-3.01M	-2.65M	-2.18M	-2.01M	-1.57M	-5.5M	-4.74M	-6.04M	-4.92M	-4.74M	-1.8M	-3.08M	-150.83K	-643.4K	-368.23K	-222.4K	-266.25K	-277.88K	-293.85K	-293.85K
Capital Expenditures	n/a	3.00	-3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.01M	n/a	-493.48K	n/a	n/a	72.1K	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	299.21K	2.62M	1.65M	453.95K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.88K	-3.02M	n/a	-2.22M	-50.88K	n/a	n/a	n/a	n/a	300K	312.5K	312.5K
Financial Cash Flow	4.37M	2.62M	1.65M	453.95K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.88K	35.99M	n/a	15.29M	-50.88K	483K	541K	425K	200K	300K	312.5K	312.5K
Net Cash Flow	1.5M	-1.85M	4.6K	-7.28M	-3.01M	-2.65M	-2.18M	-2.01M	-1.57M	-5.5M	-4.74M	-6.04M	-4.87M	31.25M	-1.8M	12.21M	-201.71K	-160.4K	172.77K	202.6K	-66.25K	22.12K	18.65K	18.65K
Free Cash Flow	-2.87M	-4.47M	-1.64M	-7.73M	-3.01M	-2.65M	-2.18M	-2.01M	-1.57M	-5.5M	-4.74M	-6.04M	-4.92M	-4.74M	-1.8M	-3.08M	-150.83K	-643.4K	-368.23K	-222.4K	-266.25K	-277.88K	-293.85K	-293.85K